BenchSci, a pioneer in AI solutions for preclinical research and drug discovery, has forged a strategic partnership with Thermo Fisher Scientific Inc., a global leader in scientific innovation. This collaboration aims to develop AI-driven research tools and digital capabilities that enhance experimental design and R&D productivity for scientists. Utilizing BenchSci’s ASCEND™ AI technology, the partnership will create advanced enterprise software solutions, optimized reagent selection, and comprehensive research literature searches. These tools will empower researchers to interpret large datasets, design efficient experiments, and optimize laboratory resources. As Liran Belenzon, CEO of BenchSci, highlights, their AI technology acts as an invaluable assistant for scientists. Gianluca Pettiti of Thermo Fisher reflects that this partnership will revolutionize scientific modeling and expedite the journey from research to approved medicines. With robust funding exceeding $200 million and support from top investors, BenchSci is committed to accelerating the R&D process for life-saving drugs. For more information, visit www.benchsci.com.
Source link
